spacer gif spacer gif spacer gif spacer gif ARCHIVE ANNOUNCEMENT! spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 4 October 2006
doi: 10.1242/dev.02610

Development 133, 4245-4256 (2006)
Published by The Company of Biologists 2006
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
dev.02610v1
133/21/4245    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Development
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Creemers, E. E.
Right arrow Articles by Olson, E. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Creemers, E. E.
Right arrow Articles by Olson, E. N.

Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development

Esther E. Creemers1, Lillian B. Sutherland1, John McAnally1, James A. Richardson1,2 and Eric N. Olson1,*

1 Department of Molecular Biology, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA.
2 Department of Pathology, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA.

* Author for correspondence (e-mail: eric.olson{at}utsouthwestern.edu)

Accepted 5 September 2006

Myocardin is a transcriptional co-activator of serum response factor (Srf), which is a key regulator of the expression of smooth and cardiac muscle genes. Consistent with its role in regulating cardiovascular development, myocardin is the earliest known marker specific to both the cardiac and smooth muscle lineages during embryogenesis. To understand how the expression of this early transcriptional regulator is initiated and maintained, we scanned 90 kb of genomic DNA encompassing the myocardin gene for cis-regulatory elements capable of directing myocardin transcription in cardiac and smooth muscle lineages in vivo. Here, we describe an enhancer that controls cardiovascular expression of the mouse myocardin gene during mouse embryogenesis and adulthood. Activity of this enhancer in the heart and vascular system requires the combined actions of the Mef2 and Foxo transcription factors. In addition, the Tead transcription factor is required specifically for enhancer activation in neural-crest-derived smooth muscle cells and dorsal aorta. Notably, myocardin also regulates its own enhancer, but in contrast to the majority of myocardin target genes, which are dependent on Srf, myocardin acts through Mef2 to control its enhancer. These findings reveal an Srf-independent mechanism for smooth and cardiac muscle-restricted transcription and provide insight into the regulatory mechanisms responsible for establishing the smooth and cardiac muscle phenotypes during development.

Key words: Mouse, Myocardin, Smooth muscle, Enhancer, Transcriptional regulation, Transgene


Related articles in Development:

An enhanced view of myocardin transcription

Development 2006 133: e2103. [Full Text]  



This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. S. Parmacek
Myocardin: Dominant Driver of the Smooth Muscle Cell Contractile Phenotype
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1416 - 1417.
[Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
X. Long, R. D. Bell, W. T. Gerthoffer, B. V. Zlokovic, and J. M. Miano
Myocardin Is Sufficient for a Smooth Muscle-Like Contractile Phenotype
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1505 - 1510.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Du, R. L. S. Perry, N. B. Nowacki, J. W. Gordon, J. Salma, J. Zhao, A. Aziz, J. Chan, K. W. M. Siu, and J. C. McDermott
Protein Kinase A Represses Skeletal Myogenesis by Targeting Myocyte Enhancer Factor 2D
Mol. Cell. Biol., May 1, 2008; 28(9): 2952 - 2970.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
N. C. Chi, R. M. Shaw, S. De Val, G. Kang, L. Y. Jan, B. L. Black, and D. Y.R. Stainier
Foxn4 directly regulates tbx2b expression and atrioventricular canal formation
Genes & Dev., March 15, 2008; 22(6): 734 - 739.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Yoshida
MCAT Elements and the TEF-1 Family of Transcription Factors in Muscle Development and Disease
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 8 - 17.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. L. Reyes-Juarez, R. Juarez-Rubi, G. Rodriguez, and A. Zarain-Herzberg
Transcriptional Analysis of the Human Cardiac Calsequestrin Gene in Cardiac and Skeletal Myocytes
J. Biol. Chem., December 7, 2007; 282(49): 35554 - 35563.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
M. J. Potthoff and E. N. Olson
MEF2: a central regulator of diverse developmental programs
Development, December 1, 2007; 134(23): 4131 - 4140.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
N. A. Pidkovka, O. A. Cherepanova, T. Yoshida, M. R. Alexander, R. A. Deaton, J. A. Thomas, N. Leitinger, and G. K. Owens
Oxidized Phospholipids Induce Phenotypic Switching of Vascular Smooth Muscle Cells In Vivo and In Vitro
Circ. Res., October 12, 2007; 101(8): 792 - 801.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Long and J. M. Miano
Remote Control of Gene Expression
J. Biol. Chem., June 1, 2007; 282(22): 15941 - 15945.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 2006